Clostridium difficile colitis associated with cancer chemotherapy

Area of Science:

• Oncology
• Infectious Diseases
• Gastroenterology

Background:

• Chemotherapy for malignant neoplasms can induce gastrointestinal side effects like diarrhea and enterocolitis.
• Clostridium difficile infection is a known complication in healthcare settings.

Observation:

• Two cancer patients developed colitis post-chemotherapy.
• Clostridium difficile and its toxin were identified in their stool samples.
• The bacteria was also found on fomites and healthcare workers in one patient's room.

Findings:

• Diarrhea and colitis in both patients resolved after treatment with oral vancomycin hydrochloride.
• This suggests a causal link between Clostridium difficile and chemotherapy-induced enterocolitis.

Implications:

• Patients with cancer experiencing diarrhea or colitis symptoms should be tested for toxigenic Clostridium difficile.
• Implementing appropriate isolation techniques is crucial to prevent Clostridium difficile transmission in oncology units.